Early inflammation in the airways of a cystic fibrosis foetus

[en] In cystic fibrosis patients, inflammation is often considered to be secondary to chronic infections. In the present study, we show increased levels of pro-inflammatory proteins in the lungs of a cystic fibrosis foetus compared to the lungs of two normal foetuses. Our findings suggest therefore the existence of an early intrinsic pro-inflammatory state in cystic fibrosis airways. (C) 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Verhaeghe, C.

Delbecque, Katty ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique

de Leval, Laurence ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques

Oury, Cécile ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Génétique générale et humaine

Bours, Vincent ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Génétique générale et humaine

Language :

English

Title :

Early inflammation in the airways of a cystic fibrosis foetus

Publication date :

July 2007

Journal title :

Journal of Cystic Fibrosis

ISSN :

1569-1993

eISSN :

1873-5010

Publisher :

Elsevier Science Bv, Amsterdam, Netherlands

Volume :

Issue :

Pages :

304-308

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 23 October 2009

Statistics

Number of views

218 (5 by ULiège)

Number of downloads

192 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Abstracts of the 28th European Cystic Fibrosis Conference, Hersonissos, Crete, Greece, 22-25 June 2005. J Cyst Fibros 2005; 4 Suppl 1:S1-143, SI-IX.
Lyczak J.B., Cannon C.L., and Pier G.B. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15 (2002) 194-222
Chow C.W., Landau L.I., and Taussig L.M. Bronchial mucous glands in the newborn with cystic fibrosis. Eur J Pediatr 139 (1982) 240-243
Ornoy A., Arnon J., Katznelson D., Granat M., Caspi B., and Chemke J. Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis. Am J Med Genet 28 (1987) 935-947
Bonfield T.L., Konstan M.W., and Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 104 (1999) 72-78
Khan T.Z., Wagener J.S., Bost T., Martinez J., Accurso F.J., and Riches D.W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151 (1995) 1075-1082
Noah T.L., Black H.R., Cheng P.W., Wood R.E., and Leigh M.W. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 175 (1997) 638-647
Mall M., Grubb B.R., Harkema J.R., O'Neal W.K., and Boucher R.C. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10 (2004) 487-493
Knorre A., Wagner M., Schaefer H.E., Colledge W.H., and Pahl H.L. DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs. Biol Chem 383 (2002) 271-282
Venkatakrishnan A., Stecenko A.A., King G., Blackwell T.R., Brigham KL., Christman JW., et al. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 23 (2000) 396-403
Tabary O., Escotte S., Couetil J.P., Hubert D., Dusser D., Puchelle E., et al. Relationship between IkappaBalpha deficiency, NFkappaB activity and interleukin-8 production in CF human airway epithelial cells. Pflugers Arch 443 Suppl 1 (2001) S40-S44
DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., and Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388 (1997) 548-554
Armstrong D.S., Hook S.M., Jamsen K.M., Nixon G.M., Carzino R., Carlin J.B., et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 40 (2005) 500-510
Dakin C.J., Numa A.H., Wang H., Morton J.R., Vertzyas C.C., and Henry R.L. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 165 (2002) 904-910
Delacourt C. Inflammation and cystic fibrosis. Arch Pediatr 10 Suppl 2 (2003) 338s-341s
Gillet L., Daix V., Donofrio G., Wagner M., Koszinowski U.H., China B., et al. Development of bovine herpes virus 4 as an expression vector using bacterial artificial chromosome cloning. J Gen Virol 86 (2005) 907-917
Rollins B.J. Chemokines. Blood 90 (1997) 909-928
Guo R.F., and Ward P.A. Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic Biol Med 33 (2002) 303-310
Kinnman N., Lindblad A., Housset C., Buentke E., Scheynius A., Strandvik B., et al. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis. Hepatology 32 (2000) 334-340
Raia V., Maiuri L., de Ritis G., de Vizia B., Vacca L., Conte R., et al. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res 47 (2000) 344-350
Hubeau C., Lorenzato M., Couetil J.P., Hubert D., Dusser D., Puchelle E., et al. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol 124 (2001) 69-76
Zaman M.M., Gelrud A., Junaidi O., Regan M.M., Warny M., Shea J.C., et al. Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol 11 (2004) 819-824
Park G.Y., and Christman J.W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol 290 (2006) L797-L805
Kuwano T., Nakao S., Yamamoto H., Tsuneyoshi M., Yamamoto T., Kuwano M., et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 18 (2004) 300-310
Cox D.G., Crusius J.B., Peeters P.H., Bueno-de-Mesquita H.B., Pena A.S., and Canzian F. Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease. World J Gastroenterol 11 (2005) 6003-6008
Rajah R., Nachajon R.V., Collins M.H., Hakonarson H., Grunstein M.M., and Cohen P. Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol 20 (1999) 199-208
Imai K., Dalal S.S., Chen E.S., Downey R., Schulman L.L., Ginsburg M., et al. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 163 (2001) 786-791
Pardo A., and Selman M. MMP-1: the elder of the family. Int J Biochem Cell Biol 37 (2005) 283-288
Ray A., Kuroki K., Cook J.L., Bal B.S., Kenter K., Aust G., et al. Induction of matrix metalloproteinase 1 gene expression is regulated by inflammation-responsive transcription factor SAF-1 in osteoarthritis. Arthritis Rheum 48 (2003) 134-145
Yamamoto K., Arakawa T., Ueda N., and Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270 (1995) 31315-31320
Vincenti M.P., Coon C.I., and Brinckerhoff C.E. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. Arthritis Rheum 41 (1998) 1987-1994
Tian B., Nowak D.E., Jamaluddin M., Wang S., and Brasier A.R. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. J Biol Chem 280 (2005) 17435-17448
van de Stolpe A., Caldenhoven E., Stade B.G., Koenderman L., Raaijmakers J.A., Johnson J.P., et al. 12-O-tetradecanoylphorbol-13-acetate-and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J Biol Chem 269 (1994) 6185-6192
Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2 (2002) 725-734
Viatour P., Merville M.P., Bours V., and Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30 (2005) 43-52
Giuliani C., Napolitano G., Bucci I., Montani V., and Monaco F. Nf-kB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications. Clin Ter 152 (2001) 249-253